Medicus Pharma Ltd. MDCX, MDCXW on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001997296
0001997296
EIN:
98-1778211
98-1778211
LEI:
(CF Office: 03 Life Sciences)
Business address:
300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Phone: 610-540-7515
300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Phone: 610-540-7515
Mailing address:
300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Category:
Non-accelerated filer
Smaller reporting company
Emerging growth company
Non-accelerated filer
Smaller reporting company
Emerging growth company
Filings:
68 EDGAR filings since October 13, 2023
68 EDGAR filings since October 13, 2023
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- April 4, 2025 - 1-A POS: Post-qualification amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- April 4, 2025 - POS AM: Post-Effective amendments for registration statement Open documentClick to Open document FilingOpen filingClick to Open filing
- April 2, 2025 - QUALIF: Notice of Qualification [Regulation A] Open documentClick to Open document FilingOpen filingClick to Open filing
- March 28, 2025 - 1-A POS: Post-qualification amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 28, 2025 - 253G2: *Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- March 25, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- March 20, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- March 11, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- February 11, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 28, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
- April 3, 2025 - 3/A: Initial statement of beneficial ownership of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 10, 2025 - 3/A: Initial statement of beneficial ownership of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 23, 2025 - 3/A: Initial statement of beneficial ownership of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 13, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 10, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 10, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 68 entries
Data source:
CIK0001997296.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
